Private Equity

A new partnership aims to power a tech boom in Southwest Virginia with a massive gas-fired plant, sparking hopes for revival and questions about energy.

Avantor appoints financial heavyweight Simon Dingemans to its board, a strategic move to accelerate its ambitious turnaround amid market pressures.

Revelstoke Mountain Resort unveils new luxury homes, fueling its transformation into a year-round hub amid a local housing crunch and soaring demand.

Asia Pacific Wire & Cable is raising $33.9M via a rights offer to fund its US expansion. Shareholders must now weigh participation against dilution risk.

With a key drill target identified at its Rio Tinto-partnered project in Montana, the junior explorer is poised for a pivotal year in the hunt for copper.

Pharma giant GSK partners with biotech CAMP4, leveraging novel RNA-boosting tech to develop new therapies for neurodegenerative and kidney diseases.

Struggling Inno Holdings rolls the dice with a massive reverse stock split to avoid delisting, but grim financials and a brutal market reaction raise alarms.

With a massive potential loan, the U.S. government is backing a plan to mine in Alaska and manufacture in Ohio, aiming to end its reliance on foreign graphite.

The neuro-focused biotech just acquired a late-stage cancer drug, securing massive funding. Is this a brilliant diversification or a high-stakes gamble?

Lincoln Gold secures $850k in a high-interest deal with its own chairman, funding Nevada projects but setting the stage for a shareholder vote on control.

The iconic Indian snack giant partners with a global investment firm to accelerate international growth, leveraging deep operational expertise and capital.

With a pivotal FDA date set for June 2026, Achieve Life Sciences heads to the J.P. Morgan conference to discuss its promising anti-smoking drug.

An international expert panel endorses an advanced wound therapy, potentially revolutionizing patient recovery and boosting a key player in the med-tech market.

A 120-day 'Cape to Cape' voyage introduces complimentary expedition adventures, setting a new standard for ultra-luxury world cruising.

Hong Kong's Flourishan partners with local leader Vena Nova, positioning Calgary at the forefront of the booming sustainable lab-grown diamond market.

Leading wellness franchise Prime IV Hydration & Wellness lands major financing to accelerate its rapid expansion in the booming IV therapy market.

The drone taxi market is projected to soar to $3.8 billion by 2032. But can regulators, infrastructure, and public trust keep up with the hype?

A Phase 1 trial for Moleculin's WP1066 shows encouraging safety and anti-tumor activity for children with deadly brain tumors like DIPG.

NorthStar Medical Radioisotopes will showcase its revolutionary cancer-fighting isotopes, Ac-225 and Cu-67, at the prestigious J.P. Morgan conference.

A strategic investment from a defense-focused fund aims to accelerate LEAP's responsive launch systems, signaling a new era for U.S. space superiority.